IL17A and inflammatory bowel disease: Although both share the common pathogenic mechanisms, it was shown that patients with SpA and IBD differ in circulating IL-17/IL-23 axis cytokines and integrins, regardless of symptoms.8 In addition, these conditions are separate clinical entities; while SpA mainly damages the spine and/or peripheral joints, IBD primarily affects the gastrointestinal tract.